Advanced nasopharyngeal carcinoma treated with chemotherapy and radiotherapy: Distant metastasis and local recurrence

Kouichi Isobe, Hisao Ito, Naoyuki Shigematsu, Tetuya Kawada, Shigeo Yasuda, Ryusuke Hara, Namio Machida, Hideyuki Takano, Yoshitaka Uchida, Takashi Uno, Hiroshi Kitahara, Atsushi Kubo

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

One hundred and twenty-nine patients with NPC treated at the Department of Radiology, Chiba University Hospital and Keio University Hospital from 1980 through 1993 were selected for this study. Forty-four patients received cisplatin (CDDP)- or carboplatin-based chemotherapy, and 58 patients received adriamycin (ADM)- and/or 5-FU-based chemotherapy. The remaining 27 patients were treated with radiotherapy alone. The median radiation dose to the nasopharyngeal region was 64 Gy, and to the initially involved cervical node, 60 Gy. The 5 year survival rates for the CDDP, the ADM/5-FU and the radiation alone groups were 61%, 47% and 42%, respectively. The cumulative incidences of local control in the CDDP, the ADM/5-FU and the radiation alone groups were 77%, 49% and 53% respectively. The CDDP group achieved the significantly better local control (CDDP vs ADM: p=0.001). The overall incidence of distant metastases was 54% in the CDDP group. On the other hand, it was 24% in the ADM/5-FU group and 22% in the radiation alone group (CDDP vs ADM: p=0.048). While the locoregional control rate was significantly better in the CDDP given group, more distant metastases were seen in this group.

Original languageEnglish
Pages (from-to)1183-1187
Number of pages5
JournalInternational Journal of Oncology
Volume12
Issue number5
Publication statusPublished - 1998
Externally publishedYes

Fingerprint

Doxorubicin
Radiotherapy
Neoplasm Metastasis
Recurrence
Drug Therapy
Fluorouracil
Radiation
Carboplatin
Incidence
Radiology
Cisplatin
Nasopharyngeal carcinoma
Survival Rate

Keywords

  • Chemotherapy
  • Distant metastasis
  • Locoregional control
  • Nasopharyngeal carcinoma
  • Radiotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Advanced nasopharyngeal carcinoma treated with chemotherapy and radiotherapy : Distant metastasis and local recurrence. / Isobe, Kouichi; Ito, Hisao; Shigematsu, Naoyuki; Kawada, Tetuya; Yasuda, Shigeo; Hara, Ryusuke; Machida, Namio; Takano, Hideyuki; Uchida, Yoshitaka; Uno, Takashi; Kitahara, Hiroshi; Kubo, Atsushi.

In: International Journal of Oncology, Vol. 12, No. 5, 1998, p. 1183-1187.

Research output: Contribution to journalArticle

Isobe, K, Ito, H, Shigematsu, N, Kawada, T, Yasuda, S, Hara, R, Machida, N, Takano, H, Uchida, Y, Uno, T, Kitahara, H & Kubo, A 1998, 'Advanced nasopharyngeal carcinoma treated with chemotherapy and radiotherapy: Distant metastasis and local recurrence', International Journal of Oncology, vol. 12, no. 5, pp. 1183-1187.
Isobe, Kouichi ; Ito, Hisao ; Shigematsu, Naoyuki ; Kawada, Tetuya ; Yasuda, Shigeo ; Hara, Ryusuke ; Machida, Namio ; Takano, Hideyuki ; Uchida, Yoshitaka ; Uno, Takashi ; Kitahara, Hiroshi ; Kubo, Atsushi. / Advanced nasopharyngeal carcinoma treated with chemotherapy and radiotherapy : Distant metastasis and local recurrence. In: International Journal of Oncology. 1998 ; Vol. 12, No. 5. pp. 1183-1187.
@article{7c1c31e8b37d4babbc9dedc9e4bf2d12,
title = "Advanced nasopharyngeal carcinoma treated with chemotherapy and radiotherapy: Distant metastasis and local recurrence",
abstract = "One hundred and twenty-nine patients with NPC treated at the Department of Radiology, Chiba University Hospital and Keio University Hospital from 1980 through 1993 were selected for this study. Forty-four patients received cisplatin (CDDP)- or carboplatin-based chemotherapy, and 58 patients received adriamycin (ADM)- and/or 5-FU-based chemotherapy. The remaining 27 patients were treated with radiotherapy alone. The median radiation dose to the nasopharyngeal region was 64 Gy, and to the initially involved cervical node, 60 Gy. The 5 year survival rates for the CDDP, the ADM/5-FU and the radiation alone groups were 61{\%}, 47{\%} and 42{\%}, respectively. The cumulative incidences of local control in the CDDP, the ADM/5-FU and the radiation alone groups were 77{\%}, 49{\%} and 53{\%} respectively. The CDDP group achieved the significantly better local control (CDDP vs ADM: p=0.001). The overall incidence of distant metastases was 54{\%} in the CDDP group. On the other hand, it was 24{\%} in the ADM/5-FU group and 22{\%} in the radiation alone group (CDDP vs ADM: p=0.048). While the locoregional control rate was significantly better in the CDDP given group, more distant metastases were seen in this group.",
keywords = "Chemotherapy, Distant metastasis, Locoregional control, Nasopharyngeal carcinoma, Radiotherapy",
author = "Kouichi Isobe and Hisao Ito and Naoyuki Shigematsu and Tetuya Kawada and Shigeo Yasuda and Ryusuke Hara and Namio Machida and Hideyuki Takano and Yoshitaka Uchida and Takashi Uno and Hiroshi Kitahara and Atsushi Kubo",
year = "1998",
language = "English",
volume = "12",
pages = "1183--1187",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - Advanced nasopharyngeal carcinoma treated with chemotherapy and radiotherapy

T2 - Distant metastasis and local recurrence

AU - Isobe, Kouichi

AU - Ito, Hisao

AU - Shigematsu, Naoyuki

AU - Kawada, Tetuya

AU - Yasuda, Shigeo

AU - Hara, Ryusuke

AU - Machida, Namio

AU - Takano, Hideyuki

AU - Uchida, Yoshitaka

AU - Uno, Takashi

AU - Kitahara, Hiroshi

AU - Kubo, Atsushi

PY - 1998

Y1 - 1998

N2 - One hundred and twenty-nine patients with NPC treated at the Department of Radiology, Chiba University Hospital and Keio University Hospital from 1980 through 1993 were selected for this study. Forty-four patients received cisplatin (CDDP)- or carboplatin-based chemotherapy, and 58 patients received adriamycin (ADM)- and/or 5-FU-based chemotherapy. The remaining 27 patients were treated with radiotherapy alone. The median radiation dose to the nasopharyngeal region was 64 Gy, and to the initially involved cervical node, 60 Gy. The 5 year survival rates for the CDDP, the ADM/5-FU and the radiation alone groups were 61%, 47% and 42%, respectively. The cumulative incidences of local control in the CDDP, the ADM/5-FU and the radiation alone groups were 77%, 49% and 53% respectively. The CDDP group achieved the significantly better local control (CDDP vs ADM: p=0.001). The overall incidence of distant metastases was 54% in the CDDP group. On the other hand, it was 24% in the ADM/5-FU group and 22% in the radiation alone group (CDDP vs ADM: p=0.048). While the locoregional control rate was significantly better in the CDDP given group, more distant metastases were seen in this group.

AB - One hundred and twenty-nine patients with NPC treated at the Department of Radiology, Chiba University Hospital and Keio University Hospital from 1980 through 1993 were selected for this study. Forty-four patients received cisplatin (CDDP)- or carboplatin-based chemotherapy, and 58 patients received adriamycin (ADM)- and/or 5-FU-based chemotherapy. The remaining 27 patients were treated with radiotherapy alone. The median radiation dose to the nasopharyngeal region was 64 Gy, and to the initially involved cervical node, 60 Gy. The 5 year survival rates for the CDDP, the ADM/5-FU and the radiation alone groups were 61%, 47% and 42%, respectively. The cumulative incidences of local control in the CDDP, the ADM/5-FU and the radiation alone groups were 77%, 49% and 53% respectively. The CDDP group achieved the significantly better local control (CDDP vs ADM: p=0.001). The overall incidence of distant metastases was 54% in the CDDP group. On the other hand, it was 24% in the ADM/5-FU group and 22% in the radiation alone group (CDDP vs ADM: p=0.048). While the locoregional control rate was significantly better in the CDDP given group, more distant metastases were seen in this group.

KW - Chemotherapy

KW - Distant metastasis

KW - Locoregional control

KW - Nasopharyngeal carcinoma

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=13144275282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13144275282&partnerID=8YFLogxK

M3 - Article

C2 - 9538147

AN - SCOPUS:13144275282

VL - 12

SP - 1183

EP - 1187

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 5

ER -